ホーム › 腎臓がん（腎細胞がん） › ウィスコンシン
ウィスコンシンにおける腎臓がん（腎細胞がん）の臨床試験
ウィスコンシン内の拠点で、腎臓がん（腎細胞がん）に関する12件の研究が参加者を募集しています。
ウィスコンシン内の都市
- Milwaukee8件の研究
- Green Bay6件の研究
- Madison5件の研究
- Sheboygan5件の研究
- Manitowoc4件の研究
- Racine4件の研究
- Oshkosh4件の研究
- Wausau4件の研究
- Kenosha4件の研究
- Stevens Point4件の研究
- Watertown3件の研究
- Eau Claire3件の研究
- West Bend3件の研究
公式研究テキスト（英語）
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- University of Wisconsin - Carbone Cancer Center, Madison
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06234605Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- 他50件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #33, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Duluth Clinic Ashland, Ashland
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- 他25件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- Langlade Hospital and Cancer Center, Antigo
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
- 他28件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05327686Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Minnesota Oncology Hematology, P.A., Hudson
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- ThedaCare Regional Cancer Center, Appleton
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
- Froedtert and The Medical College of Wisconsin, Milwaukee
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07188896Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- ThedaCare Regional Cancer Center, Appleton
- Duluth Clinic Ashland, Ashland
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- 他30件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06661720Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT06582017KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- University of Wisconsin (Carbone Cancer Center), Madison
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/08更新 · NCT06026410Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- Marshfield Clinic-Chippewa Center, Chippewa Falls
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- 他28件
被験者募集中第3相
18歳以上 · 全性別 · 2025/09/09更新 · NCT04510597ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。